Clinical Trials Sponsored by Noden Pharma
Total 8323 results
-
UCB PharmaCompletedCrohn's DiseaseUnited States, France, Italy, United Kingdom, Belgium, Germany, Spain, Switzerland, Canada, Netherlands, Austria, Sweden
-
UCB PharmaCompletedCrohn's DiseaseUnited States, France, Italy, United Kingdom, Belgium, Germany, Spain, Switzerland, Canada, Netherlands, Denmark, Austria, Norway, Sweden
-
Dermis PharmaCompleted
-
UCB PharmaCompletedRheumatoid ArthritisUnited States, France, Canada
-
UCB PharmaCompletedOpen Label Long-Term Safety Study of Certolizumab Pegol (CZP) for Patients With Rheumatoid ArthritisRheumatoid ArthritisUnited States, United Kingdom, Belgium, Germany, Austria, Ireland, Czechia
-
UCB PharmaCompletedRheumatoid ArthritisUnited States, France, Italy, Germany, Spain, Canada, Netherlands
-
UCB PharmaCompletedRheumatoid ArthritisUnited States, Canada
-
UCB PharmaCompletedRheumatoid ArthritisGermany, United States, Argentina, Australia, Austria, Belgium, Canada, Colombia, Czechia, France, Hungary, Ireland, Italy, Mexico, Monaco, Netherlands, Poland, Romania, Spain, Sweden, Switzerland, United Kingdom
-
UCB PharmaCompletedFibromyalgia SyndromeUnited States
-
UCB PharmaCompleted
-
UCB PharmaCompletedEpilepsyUnited States, Czechia, Germany, Poland
-
LEO PharmaTerminated
-
Kukje PharmaCompletedOcular Hypertension | Glaucoma | Eye DiseasesKorea, Republic of
-
Zealand PharmaCompleted
-
LEO PharmaCompleted
-
UCB PharmaCompletedEpilepsyFrance, Poland, United Kingdom, Germany, Spain, Finland, Australia, Russian Federation, Hungary, Lithuania, Sweden, Czechia, Croatia
-
LEO PharmaCompleted
-
Vifor PharmaCompletedChronic Heart Failure | Iron DeficiencyNetherlands
-
LEO PharmaCompletedAnogenital WartsDenmark
-
LEO PharmaCompleted
-
Zealand PharmaCompletedDiabetes Mellitus Type 1Germany
-
Innate PharmaTerminatedSquamous Cell Carcinoma of the Oral CavityGermany, Spain
-
Patara PharmaCompletedSystemic Mastocytosis | Mastocytosis | Indolent Systemic MastocytosisFrance, Germany, Spain, Italy, Netherlands
-
LEO PharmaCompleted
-
LEO PharmaCompletedPsoriasis VulgarisUnited Kingdom
-
LEO PharmaCompletedSkin and Connective Tissue DiseasesJapan
-
UCB PharmaCompletedSystemic Lupus ErythematosusJapan
-
PLx PharmaCompletedDiabetes Mellitus, Type 2United States
-
Advanz PharmaCompleted
-
Zealand PharmaCompleted
-
LEO PharmaCompletedScalp PsoriasisUnited States
-
AM-PharmaWithdrawnFungal Infection | Bacterial InfectionNetherlands
-
UCB PharmaCompletedFibromyalgia SyndromeUnited States
-
LEO PharmaCompleted
-
Sigmoid PharmaCompleted
-
LEO PharmaCompleted
-
UCB PharmaCompletedEpilepsy, FocalFrance, Poland, United Kingdom, Belgium, Germany, Spain, Czech Republic, Finland, Netherlands
-
LEO PharmaCompletedPsoriasis of ScalpCanada, Denmark, France, Norway, Portugal, Spain, Sweden, United Kingdom
-
LEO PharmaCompletedPsoriasis VulgarisBelgium, Canada, France, Germany, Netherlands, Spain, United Kingdom
-
LEO PharmaCompletedPsoriasis of ScalpFrance, Canada, Belgium, Denmark, Sweden
-
LEO PharmaCompletedPsoriasis VulgarisIreland, Germany, United Kingdom, Canada, Sweden
-
LEO PharmaCompletedPsoriasisUnited States
-
UCB PharmaCompletedAllergic Rhinitis | Chronic UrticariaUnited States
-
Innate PharmaCompletedInflammation | Rheumatoid ArthritisGermany
-
UCB PharmaCompletedEpilepsyFrance, Germany, Greece, Italy, Poland, Spain, United Kingdom
-
UCB PharmaCompletedGeneralized Anxiety Disorder | Panic DisorderUnited States
-
UCB PharmaCompletedParkinson's DiseaseUnited States, Chile, Mexico, India, Peru
-
UCB PharmaTerminatedParkinson's DiseaseSpain, South Africa, New Zealand, Hungary, United States, Germany, Italy, Australia, Finland, United Kingdom, Poland